Detalles de la búsqueda
1.
Experiences of parents and caregivers in pediatric intensive care units: A qualitative study.
Arch Pediatr
; 29(8): 554-559, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36210238
2.
Neodymium-yttrium aluminium garnet laser destruction of nonsensitized and hematoporphyrin derivative-sensitized tumors.
Cancer Res
; 43(6): 2876-9, 1983 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-6850599
3.
Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
J Clin Oncol
; 12(2): 353-9, 1994 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-8113843
4.
Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.
J Clin Oncol
; 13(5): 1221-30, 1995 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-7738625
5.
A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.
J Clin Oncol
; 8(9): 1556-62, 1990 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-2167953
6.
Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party.
J Clin Oncol
; 11(10): 1858-65, 1993 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-8410110
7.
Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.
J Clin Oncol
; 7(8): 1087-92, 1989 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-2547028
8.
Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer. European Lung Cancer Working Party.
Eur J Cancer
; 30A(9): 1342-7, 1994.
Artículo
en Inglés
| MEDLINE | ID: mdl-7999423
9.
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party.
Eur J Cancer
; 33(14): 2326-32, 1997 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-9616276
10.
Phase I/II study of gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results.
Semin Oncol
; 23(5 Suppl 10): 43-7, 1996 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-8893881
11.
A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party.
Semin Oncol
; 17(1 Suppl 2): 20-4, 1990 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-2154855
12.
Prognostic factors in diffuse malignant pleural mesothelioma. A study of 167 patients.
Chest
; 93(1): 159-62, 1988 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-3335148
13.
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer.
Lung Cancer
; 11(5-6): 373-84, 1994 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-7704494
14.
Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice.
Lung Cancer
; 29(3): 205-16, 2000 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-10996423
15.
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC).
Lung Cancer
; 16(1): 21-33, 1996 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-9017582
16.
Cloning of a human cancer cell line (NSCLC-N6) and comparative study of the clones in vitro.
Anticancer Res
; 18(1A): 193-200, 1998.
Artículo
en Inglés
| MEDLINE | ID: mdl-9568077
17.
Terminal differentiation in a non-small-cell bronchopulmonary carcinoma correlates with increased expression of p53.
Anticancer Res
; 16(3A): 1209-12, 1996.
Artículo
en Inglés
| MEDLINE | ID: mdl-8702238
18.
Correlation between multidrug resistance and the degree of differentiation of non-small-cell bronchopulmonary carcinoma (NSCLC) in vitro and in vivo.
Anticancer Res
; 17(6D): 4595-8, 1997.
Artículo
en Inglés
| MEDLINE | ID: mdl-9494574
19.
A phase II study of Navelbine (vinorelbine) in the treatment of non-small-cell lung cancer.
Am J Clin Oncol
; 14(2): 115-9, 1991 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-1851385
20.
[Efficacy of the combination of mitomycin, ifosfamide and cisplatin with irradiation for the treatment of cerebral metastasis in non small cell lung carcinoma]. / Efficacité de l'association mitomycine, ifosfamide, cisplatine avec irradiation pour le traitement des métastases cérébrales des cancers bronchiques non à petites cellules.
Bull Cancer
; 82(1): 57-62, 1995 Jan.
Artículo
en Francés
| MEDLINE | ID: mdl-7742617